コンパニオンアニマルヘルスの世界市場2023-2028:産業動向、シェア、規模、成長、機会・予測

◆英語タイトル:Companion Animal Health Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書(IMARC23AP143)◆商品コード:IMARC23AP143
◆発行会社(リサーチ会社):IMARC
◆発行日:2023年2月21日
◆ページ数:143
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single UserUSD2,999 ⇒換算¥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算¥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算¥759,848見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

アイマーク社の本調査資料によると、2022年に234億ドルであった世界のコンパニオンアニマルヘルス市場規模が、2028年までに390億ドルとなり、予測期間中にCAGR8.4%で拡大すると見込まれています。本書は、コンパニオンアニマルヘルスの世界市場を徹底的に分析し、市場の現状や今後の動向をまとめた資料です。序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、動物別(犬、猫、馬、その他)分析、製品別(ワクチン、医薬品、飼料添加物、診断、その他)分析、エンドユーザー別(ポイントオブケアテスト/インハウステスト、動物病院・診療所、その他)分析、地域別(北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ)分析、SWOT分析、バリューチェーン分析、ポーターズファイブフォース分析、価格分析、競争状況など、以下の構成で掲載しています。また、本書内には、Agrolabo S.p.A.、Boehringer Ingelheim、Ceva Santé Animale、Dechra Pharmaceuticals PLC、Elanco Animal Health Incorporated、IDEXX Laboratories Inc.、Indian Immunologicals Limited (National Dairy Development Board)、Merck & Co. Inc.、Norbrook Laboratories、Vetoquinol SA、Virbac and Zoetis Inc.など、参入企業情報が含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界のコンパニオンアニマルヘルス市場規模:動物別
- 犬における市場規模
- 猫における市場規模
- 馬における市場規模
- その他における市場規模
・世界のコンパニオンアニマルヘルス市場規模:製品別
- ワクチンの市場規模
- 医薬品の市場規模
- 飼料添加物の市場規模
- 診断の市場規模
- その他の市場規模
・世界のコンパニオンアニマルヘルス市場規模:エンドユーザー別
- ポイントオブケアテスト/インハウステストにおける市場規模
- 動物病院・診療所における市場規模
- その他における市場規模
・世界のコンパニオンアニマルヘルス市場規模:地域別
- 北米のコンパニオンアニマルヘルス市場規模
- アジア太平洋のコンパニオンアニマルヘルス市場規模
- ヨーロッパのコンパニオンアニマルヘルス市場規模
- 中南米のコンパニオンアニマルヘルス市場規模
- 中東・アフリカのコンパニオンアニマルヘルス市場規模
・SWOT分析
・バリューチェーン分析
・ポーターズファイブフォース分析
・価格分析
・競争状況

The global companion animal health market size reached US$ 23.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 39.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.4% during 2023-2028.

Companion animal health refers to the regular monitoring of the health of companion animals to detect diseases and other conditions, which can put their lives in danger if left untreated. It includes the development of monoclonal antibody therapies, therapeutic vaccines, anti-neoplastic drugs, genomic tests, and digital technologies. At present, there is a significant rise in the number of pet parents around the world who are aware about the overall health and well-being of companion animals and routinely seek veterinary services.

Companion Animal Health Market Trends:
Companion animal aging has led to a rise in the risk of tumors, obesity, osteoarthritis, cardiovascular diseases (CVDs), diabetes mellitus, and hepatic and renal diseases worldwide. This, in confluence with the growing awareness about the One Health (OH) approach initiative, which recognizes that public health is connected with animal health and the environment, represents one of the key factors creating a positive outlook for the market. This initiative is supported by the World Health Organization (WHO), Food and Agriculture Organization (FAO), and the American Veterinary Medical Association (AVMA). Moreover, having companion animals is associated with positive health benefits, including lower blood pressure, decrease anxiety, reduce cardiac arrhythmia, more psychological stability, and better well-being. Besides this, there is an increase in the utilization of animal-assisted therapy in numerous areas of human health care. This, coupled with the rising population of traditional companion animals, such as dogs and cats, is impelling the market growth. Apart from this, vaccination of companion animals, particularly dogs, against rabies helps prevent the disease in animals and humans. Furthermore, the increasing prevalence of zoonotic diseases across the globe is anticipated to facilitate the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global companion animal health market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on animal type, product and end user.

Breakup by Animal Type:
Dogs
Cats
Equine
Others

Breakup by Product:
Vaccines
Pharmaceuticals
Feed Additives
Diagnostics
Others

Breakup by End User:
Point-of-care Testing/In-house Testing
Veterinary Hospitals and Clinics
Others

Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agrolabo S.p.A., Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Indian Immunologicals Limited (National Dairy Development Board), Merck & Co. Inc., Norbrook Laboratories, Vetoquinol SA, Virbac and Zoetis Inc.

Key Questions Answered in This Report
1. What was the size of the global companion animal health market in 2022?
2. What is the expected growth rate of the global companion animal health market during 2023-2028?
3. What has been the impact of COVID-19 on the global companion animal health market?
4. What are the key factors driving the global companion animal health market?
5. What is the breakup of the global companion animal health market based on the animal type?
6. What is the breakup of the global companion animal health market based on the end user?
7. What are the key regions in the global companion animal health market?
8. Who are the key players/companies in the global companion animal health market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Companion Animal Health Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Animal Type
6.1 Dogs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Cats
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Equine
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Product
7.1 Vaccines
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Pharmaceuticals
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Feed Additives
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Diagnostics
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Point-of-care Testing/In-house Testing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Veterinary Hospitals and Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Agrolabo S.p.A.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Boehringer Ingelheim
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Ceva Santé Animale
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Dechra Pharmaceuticals PLC
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Elanco Animal Health Incorporated
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 IDEXX Laboratories Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Indian Immunologicals Limited (National Dairy Development Board)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Merck & Co. Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Norbrook Laboratories
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Vetoquinol SA
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Virbac
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Zoetis Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ コンパニオンアニマルヘルスの世界市場2023-2028:産業動向、シェア、規模、成長、機会・予測(Companion Animal Health Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆